Peptide coatings boost iron oxide-based particles for diagnostic magnetic resonance imaging 

November 16, 2018, Agency for Science, Technology and Research (A*STAR), Singapore
Peptide coatings boost iron oxide-based particles for diagnostic magnetic resonance imaging 
Peptide-coated magnetically active nanoparticles developed for contrast-enhanced MRI detect a liver tumor. Credit: American Chemical Society.

Cancer will become easier to detect and diagnose early using magnetic resonance imaging (MRI) thanks to A*STAR researchers who have engineered biocompatible iron oxide nanoparticle contrast agents¹.

While gadolinium-based compounds have proven effective as contrast agents for enhancing the signal-to-noise ratio during MRI, they can cause side effects such as the nephrogenic systemic fibrosis that can affect patients with reduced kidney function. Iron oxide have emerged as low-risk alternatives. In complex biological environments, however, these tend to degrade, aggregate, and adhere to other substances, which reduces their magnetic activity.

To mitigate this issue, a team led by David Paramelle, from the A*STAR Institute of Materials Research and Engineering, has developed peptide coatings that prevent nanoparticle decomposition and aggregation while facilitating biocompatibility. These coatings are crucial for the transition of oxide-based contrast agents to clinical use.

Building on their extensive experience of peptide-coated silver and gold nanoparticles, the researchers created a library of short peptides and deposited these compounds on the iron oxide nanoparticles to produce various single-layer films. They also synthesized analogous ligands to fill any gap between peptides on the nanoparticle surface and generate mixed coatings.

Each peptide comprised a stem connected to a 'foot' and a 'head' at each extremity. While the foot anchored the peptide to the nanoparticles, the alcohol-functionalized head stabilized the nanoparticles and stopped unwanted interactions with the environment.

"The tricky part was to find a foot with high binding strength," Paramelle explained, because, the presented a different chemistry despite their similar spherical geometry and size to gold and silver nanoparticles."

"To design the peptides, we had to go back to the drawing board," says Paramelle, noting that switching from noble metals, which preferentially bind to sulfur-containing molecules, to iron broadened the range of functional groups serving as a foot to include phosphates and carboxylic acids.

Through increasingly rigorous tests, the researchers assessed the ability of each film to stabilize the nanoparticles under biological conditions while maintaining their magnetic properties. They discovered that and ligands bearing two phosphate groups at the foot performed best in the presence of liver cancer cells. The peptide-coated nanoparticles outperformed commercially available contrast agents without destroying cells in vitro, and strongly enhanced the contrast between tumorous and healthy tissue during in vivo MRI when injected into mice with liver cancer.

Paramelle's team is investigating ways to widen the application of their system to other cancers, especially breast . "We plan to functionalize the nanoparticles with antibodies and control the number of these antibodies on the nanoparticle surface," he says.

Explore further: Rare earth orthoferrite LnFeO3 nanoparticles for bioimaging

More information: Heng Li Chee et al. Biocompatible Peptide-Coated Ultrasmall Superparamagnetic Iron Oxide Nanoparticles for In Vivo Contrast-Enhanced Magnetic Resonance Imaging, ACS Nano (2018). DOI: 10.1021/acsnano.7b07572

Related Stories

Rare earth orthoferrite LnFeO3 nanoparticles for bioimaging

September 4, 2018

Magnetic resonance imaging (MRI) has emerged as one of the most powerful clinical imaging tools because of its superb spatial resolution and soft tissue contrast, especially when using contrast agents. In the European Journal ...

New Nanoparticle Structure Boosts Magnetic Properties

December 19, 2005

Magnetic nanoparticles have shown promise as contrast-enhancing agents for improving cancer detection using magnetic resonance imaging (MRI), as miniaturized heaters capable of killing malignant cells, and as targeted drug ...

New nanoparticle delivers, tracks cancer drugs

October 29, 2013

( —UNSW chemical engineers have synthesised a new iron oxide nanoparticle that delivers cancer drugs to cells while simultaneously monitoring the drug release in real time.

Recommended for you

After a reset, Сuriosity is operating normally

February 23, 2019

NASA's Curiosity rover is busy making new discoveries on Mars. The rover has been climbing Mount Sharp since 2014 and recently reached a clay region that may offer new clues about the ancient Martian environment's potential ...

Study: With Twitter, race of the messenger matters

February 23, 2019

When NFL player Colin Kaepernick took a knee during the national anthem to protest police brutality and racial injustice, the ensuing debate took traditional and social media by storm. University of Kansas researchers have ...

Solving the jet/cocoon riddle of a gravitational wave event

February 22, 2019

An international research team including astronomers from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has combined radio telescopes from five continents to prove the existence of a narrow stream of material, ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.